This events calendar is an announcement service by CoNGO to its member organizations, its NGO substantive committees, the wider civil society community, and the UN System. All events included here, including their accuracy, are the sole responsibility of their organizers. Unless explicitly indicated, inclusion of an event in this calendar does not constitute CoNGO endorsement of the event. If you have an event or meeting you want to be considered for announcement here, please email us at infonews@ngocongo.org.
- This event has passed.
Civil Society Regional Consultation for the Americas in the lead up to the CND Mid-Term Review
18 January @ 12:00 PM - 2:00 PM UTC-5
Civil Society Regional Consultation for the Americas in
the lead up to the CND Mid-Term Review
Desplácese hacia abajo para ver la versión en español.
Por favor role para baixo para ver a versão em português.
The Vienna & New York NGO Committees are pleased to invite you to participate in the Americas regional civil society consultation in preparations for the Commission on Narcotic Drugs (CND) Mid-term review in 2024. The consultation will take place ONLINE on 18 January 12noon to 2PM EST. (please check here for converting into your respective time zone)
The CND Mid-term review is a process that aims to assess the implementation of the 2019 Ministerial Declaration on strengthening actions at the national, regional and international levels to accelerate the implementation of joint commitments to address and counter the world drug problem. The review will also identify challenges and gaps, as well as best practices and lessons learned, in order to inform future actions and strategies.
As a civil society representative working on drug related issues and based in the Americas, your participation in this consultation is valuable and important.
If you are interested in participating in this consultation, please fill out this online registration form by 15 January 2024. You will receive a confirmation email with further details and instructions on how to join the consultations.
We look forward to hearing from you and engaging with you in this important process.